These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19913149)

  • 1. Use of injectable progestin contraception and risk of STI among South African women.
    Pettifor A; Delany S; Kleinschmidt I; Miller WC; Atashili J; Rees H
    Contraception; 2009 Dec; 80(6):555-60. PubMed ID: 19913149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.
    Kleinschmidt I; Rees H; Delany S; Smith D; Dinat N; Nkala B; McIntyre JA
    Contraception; 2007 Jun; 75(6):461-7. PubMed ID: 17519153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
    AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa.
    Noguchi LM; Marrazzo JM; Richardson B; Hillier SL; Balkus JE; Palanee-Phillips T; Nair G; Panchia R; Piper J; Gomez K; Ramjee G; Chirenje ZM
    Front Reprod Health; 2021 Jul; 3():. PubMed ID: 35669097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
    Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
    Front Immunol; 2021; 12():760504. PubMed ID: 34956191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
    Balle C; Gill K; Konstantinus IN; Jaumdally SZ; Lennard K; Esra R; Happel AU; Barnabas SL; Gamieldien H; Pidwell T; Maseko V; Lesosky M; Myer L; Passmore JS; Bekker LG; Jaspan HB
    Sex Transm Infect; 2021 Mar; 97(2):112-117. PubMed ID: 32989170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
    Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
    Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L; Denny L; Wright TC; Kuhn L
    Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalent bacterial vaginosis infection - a risk factor for incident sexually transmitted infections in women in Durban, South Africa.
    Abbai NS; Reddy T; Ramjee G
    Int J STD AIDS; 2016 Dec; 27(14):1283-1288. PubMed ID: 26538552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.
    Kiweewa FM; Brown E; Mishra A; Nair G; Palanee-Phillips T; Mgodi N; Nakabiito C; Chakhtoura N; Hillier SL; Baeten JM;
    J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
    Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
    PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
    Deese J; Masson L; Miller W; Cohen M; Morrison C; Wang M; Ahmed K; Agot K; Crucitti T; Abdellati S; Van Damme L
    Am J Reprod Immunol; 2015 Oct; 74(4):357-67. PubMed ID: 26202107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa.
    Smit J; Gray A; McFadyen L; Zuma K
    BMC Health Serv Res; 2001; 1():4. PubMed ID: 11401729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.
    Avenant C; Singata-Madliki M; Bick AJ; Africander D; Balakrishna Y; Storbeck KH; Moliki JM; Dlamini S; Skosana S; Smit J; Beksinska M; Beesham I; Seocharan I; Batting J; Hofmeyr GJ; Hapgood JP
    PLoS One; 2024; 19(8):e0307736. PubMed ID: 39178280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.
    Polis CB; Phillips SJ; Curtis KM; Westreich DJ; Steyn PS; Raymond E; Hannaford P; Turner AN
    Contraception; 2014 Oct; 90(4):360-90. PubMed ID: 25183264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
    Heffron R; Achilles SL; Dorflinger LJ; Hapgood JP; Kiarie J; Polis CB; Steyn PS
    Contraception; 2019 Apr; 99(4):199-204. PubMed ID: 30576636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
    Singata-Madliki M; Smit J; Beksinska M; Balakrishna Y; Avenant C; Beesham I; Seocharan I; Batting J; Hapgood JP; Hofmeyr GJ
    PLoS One; 2024; 19(3):e0295764. PubMed ID: 38530848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.